Neal Rosen
机构: Professor of Pharmacology, Memorial Sloan-Kettering Cancer Center
每年引用次数
引用次数
引用: 63,279
H-指数: 135
I10-指数 : 280
出版物: 520
Sjögren's syndrome: severe upper airways obstruction due to primary malignant tracheal lymphoma developing during successful treatment of lymphocytic interstitial pneumonitis
S Rakoff , N Rosen , N Becker , A Sher
The Journal of Rheumatology 14 ( 3) 588 -594
24
1987
P4-32 Cellular & Molecular Characterization of Circulating Breast Tumor Cells after Leukapharesis in Breast Carcinoma (BC) Patients by RT-PCR, Immunohistochemistry (IHC), Laser Scanning Confocal Microscopy (LSCM), Laser Scanning Cytometer (LSC), and Fluorescent
S Bhattacharya , G Juan , C Hudis , HI Scher
Acta Histochemica Et Cytochemica 35 ( 3) 256
2002
Inhibition of plasminogen activator secretion by cyclic AMP in a macrophage-like cell line
N Rosen , B R Bloom , O M Rosen , J Schneck
Journal of cyclic nucleotide research 4 ( 5) 345 -358
7
1978
Alterations in the expression of pp60c-src and p56lck associated with butyrate-induced differentiation of human colon carcinoma cells.
A Veillette , N Rosen , F M Foss , J B Bolen
oncogene Research 5 ( 1) 13 -23
43
1989
Inhibitors of HSP90 block p95-HER2 signaling in Trastuzumab-resistant tumors and suppress their growth
S Chandarlapaty , M Scaltriti , P Angelini , Q Ye
Oncogene 29 ( 3) 325 -334
92
2010
PI3K inhibition results in enhanced HER signaling and acquired ERK dependency in HER2-overexpressing breast cancer
V Serra , M Scaltriti , L Prudkin , P J A Eichhorn
Oncogene 30 ( 22) 2547 -2557
574
2011
Insulin-like growth factor I expression by tumors of neuroectodermal origin with the t(11;22) chromosomal translocation. A potential autocrine growth factor.
D Yee , R E Favoni , G S Lebovic , F Lombana
Journal of Clinical Investigation 86 ( 6) 1806 -1814
153
1990
Acquired CDK6 amplification promotes breast cancer resistance to CDK4/6 inhibitors and loss of ER signaling and dependence
C Yang , Z Li , T Bhatt , M Dickler
Oncogene 36 ( 16) 2255 -2264
140
2017
Apoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin.
X Wu , Z Fan , H Masui , N Rosen
Journal of Clinical Investigation 95 ( 4) 1897 -1905
373
1995
Abstract P4-06-07: PI3K Mutations Are More Common in Low Grade DCIS
R Sakr , S Chandarlapaty , V Andrade , D Giri
Cancer Research 70
2010
PD09-08: Combined Inhibition of mTORC1 with Temsirolimus and HER2 with Neratinib: A Phase I/II Study in Patients with Metastatic HER2−Amplified or Triple-Negative Breast Cancer.
D Gajria , T King , H Pannu , R Sakr
Cancer Research 71
11
2011
Insulin-like growth factor-II overexpression in MCF-7 cells induces phenotypic changes associated with malignant progression.
K J Cullen , M E Lippman , D Chow , S Hill
Molecular Endocrinology 6 ( 1) 91 -100
118
1992
Farnesyl:protein transferase inhibitors as potential agents for the management of human prostate cancer.
L Sepp-Lorenzino , G Tjaden , MM Moasser , N Timaul
Prostate Cancer and Prostatic Diseases 4 ( 1) 33 -43
24
2001
The microtubule-stabilizing agents epothilones A and B and their desoxy-derivatives induce mitotic arrest and apoptosis in human prostate cancer cells.
L Sepp-Lorenzino , A Balog , D-S Su , D Meng
Prostate Cancer and Prostatic Diseases 2 ( 1) 41 -52
36
1999
Selective expression of alternative lck mRNAs in human malignant cell lines.
O Sartor , F S Gregory , N S Templeton , S Pawar
Molecular and Cellular Biology 9 ( 7) 2983 -2988
28
1989
Isolation of variants in phagocytosis of a macrophage-like continuous cell line.
R J Muschel , N Rosen , B R Bloom
Journal of Experimental Medicine 145 ( 1) 175 -186
46
1977
Abstract P4-08-02: Reactivation of oncogenic signaling through mTOR inhibitors-induced feedback adaptations.
V Rodrik-Outmezguine , S Chandarlapaty , P Poulikakos , M Scaltriti
Cancer Research 72
2012
Abstract P5-18-04: Tolerability and efficacy of targeting both mTOR and HER2 signaling in trastuzumab-refractory HER2+ metastatic breast cancer
D Gajria , T King , H Pannu , R Sakr
Cancer Research 72
4
2012
Abstract PD04-05: Molecular predictors for type of recurrence following conservative treatment for DCIS
RA Sakr , VP Andrade , S Chandarlapaty , C Giovanni
Cancer Research 72
2
2012
Breast tumor cells withPI3Kmutation orHER2amplification are selectively addicted to Akt signaling.
Q She , S Chandarlapaty , Q Ye , J Lobo
Cancer Research 69 3061
2
2009
David Solit Sarat Chandarlapaty Christine Pratilas Poulikos I. Poulikakos Laura Sepp-Lorenzino Qing-Bai She Gabriela Chiosis Maurizio Scaltriti Pamela Munster Rona Yaeger Zhan Yao Douglas Yee Agnes Viale Taha Merghoub Charles Sawyers Michael F Berger Madhavi Tadi Manickam Janakiraman Violeta Serra, PhD